Susquehanna International Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Susquehanna International Group’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-45,000	Closed	-$1.26M	–	11204
2019 Q3	$1.26M	Sell	45,000 -35,700	-44%	-$578K	﹤0.01%	5199
2019 Q2	$1.14M	Buy	80,700 +68,100	+540%	+$648K	﹤0.01%	5362
2019 Q1	$112K	Buy	+12,600	New	+$102K	﹤0.01%	8203
2018 Q4	–	Sell	-65,400	Closed	-$1.37M	–	10481
2018 Q3	$1.37M	Buy	+65,400	New	+$1.56M	﹤0.01%	4655

Susquehanna International Group's DOVA Position: Q3 2019 in Review

Susquehanna International Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 14,854 shares — an estimated $241K sold.

Susquehanna International Group first reported a position in DOVA in Q3 2018 and held it in 2 quarters. The position peaked at $993K in Q3 2018. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

Susquehanna International Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Susquehanna International Group sold 14,854 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $241K.
Susquehanna International Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
Susquehanna International Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $993K in Q3 2018.
72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.